ESC 365 - Trends in diuretic treatment between 2005 and 2011 in patients with heart failure

ESC Premium Access

Trends in diuretic treatment between 2005 and 2011 in patients with heart failure

Session: Poster session 5 - Chronic heart failure (CHF)

Topic: Pharmacologic therapy

Speaker: Doctor P. Paren (Gothenburg, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Par Paren

Sahlgrenska University Hospital, Gothenburg (Sweden)

0 follower

31 more presentations in this session

Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling.

Speaker: Doctor C. Santos-Gallego (New York, US)

Iron status, respiratory muscle strength, and physical fitness in men with heart failure with reduced ejection fraction

Speaker: Doctor M. Drozd (Wroclaw, PL)

Glycer-AGEs is associated with the severity of cardiac function of diabetic cardiomyopathy(DbCM).

Speaker: Assistant Professor H. Aoki (Uchinada, JP)

Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction +/- heart failure in epirubicinum recipients for bladder cancer

Speaker: Associate Professor A. Tase (Pitesti, RO)

Early, combined heart failure therapy attenuates doxorubicin cardiomyopathy in rats

Speaker: Miss M. Lodi (Debrecen, HU)

Access the full session

Poster session 5 - Chronic heart failure (CHF)

Speakers: Doctor P. Paren, Doctor C. Santos-Gallego, Doctor M. Drozd, Assistant Professor H. Aoki, Associate Professor A. Tase...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources